Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment

Milou van Heuckelum*, Elke G. E. Mathijssen, Marcia Vervloet, Annelies Boonen, Renske C. F. Hebing, Annelieke Pasma, Harald E. Vonkeman, Mark H. Wenink, Bart J. F. van den Bemt, Liset van Dijk

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1199-1211
Number of pages13
JournalPatient Preference and Adherence
Volume13
DOIs
Publication statusPublished - 2019

Keywords

  • rheumatoid arthritis
  • disease-modifying antirheumatic drugs
  • discrete choice experiment
  • treatment preferences
  • BIOLOGIC AGENTS
  • HEALTH
  • THERAPIES
  • ADHERENCE
  • ATTRIBUTES
  • FREQUENCY
  • MEDICINES
  • BELIEFS

Cite this

van Heuckelum, M., Mathijssen, E. G. E., Vervloet, M., Boonen, A., Hebing, R. C. F., Pasma, A., Vonkeman, H. E., Wenink, M. H., van den Bemt, B. J. F., & van Dijk, L. (2019). Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment. Patient Preference and Adherence, 13, 1199-1211. https://doi.org/10.2147/PPA.S204111